Screening of <i>Klebsiella pneumoniae</i> subsp. <i>pneumoniae</i> Strains with Multi-Drug Resistance and Virulence Profiles Isolated from an Italian Hospital between 2020 and 2023
Valentina Dimartino,
Carolina Venditti,
Francesco Messina,
Silvia D’Arezzo,
Marina Selleri,
Ornella Butera,
Carla Nisii,
Alessandra Marani,
Alessia Arcangeli,
Roberta Gaziano,
Terenzio Cosio,
Pietro Scanzano,
Carla Fontana
Affiliations
Valentina Dimartino
National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, 00149 Rome, Italy
Carolina Venditti
National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, 00149 Rome, Italy
Francesco Messina
National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, 00149 Rome, Italy
Silvia D’Arezzo
National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, 00149 Rome, Italy
Marina Selleri
National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, 00149 Rome, Italy
Ornella Butera
National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, 00149 Rome, Italy
Carla Nisii
National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, 00149 Rome, Italy
Alessandra Marani
Health Direction, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, 00149 Rome, Italy
Alessia Arcangeli
Health Direction, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, 00149 Rome, Italy
Roberta Gaziano
Department of Experimental Medicine, University of Rome Tor Vergata, Via Montpellier 1, 00133 Rome, Italy
Terenzio Cosio
Dermatology Unit, Department of Systems Medicine, Tor Vergata University Hospital, 00133 Rome, Italy
Pietro Scanzano
Health Direction, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, 00149 Rome, Italy
Carla Fontana
National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, 00149 Rome, Italy
Klebsiella pneumoniae strains that are resistant to multiple drugs (KPMDRs), which are often acquired in hospital settings and lead to healthcare-associated infections, pose a serious public health threat, as does hypervirulent K. pneumoniae (hvKp), which can also cause serious infections in otherwise healthy individuals. The widespread and often unnecessary use of antibiotics seen during the recent COVID-19 pandemic has exacerbated the challenges posed by antibiotic resistance in clinical settings. There is growing concern that hypervirulent (hvKp) strains may acquire genes that confer antimicrobial resistance, thus combining an MDR profile with their increased ability to spread to multiple body sites, causing difficult-to-treat infections. This study aimed to compare resistance and virulence profiles in KPC-3-producing K. pneumoniae isolates collected over four years (2020–2023). A genome-based surveillance of all MDR CRE-K. pneumoniae was used to identify genetic differences and to characterize the virulence and resistance profiles. Our results provide a picture of the evolution of resistance and virulence genes and contribute to avoiding the possible spread of isolates with characteristics of multi-drug resistance and increased virulence, which are thought to be one of the main global challenges to public health, within our hospital.